全文获取类型
收费全文 | 5534篇 |
免费 | 481篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 101篇 |
妇产科学 | 145篇 |
基础医学 | 977篇 |
口腔科学 | 104篇 |
临床医学 | 551篇 |
内科学 | 1181篇 |
皮肤病学 | 185篇 |
神经病学 | 793篇 |
特种医学 | 201篇 |
外科学 | 506篇 |
综合类 | 45篇 |
一般理论 | 4篇 |
预防医学 | 345篇 |
眼科学 | 138篇 |
药学 | 302篇 |
中国医学 | 8篇 |
肿瘤学 | 409篇 |
出版年
2024年 | 15篇 |
2023年 | 97篇 |
2022年 | 135篇 |
2021年 | 241篇 |
2020年 | 169篇 |
2019年 | 218篇 |
2018年 | 247篇 |
2017年 | 195篇 |
2016年 | 256篇 |
2015年 | 257篇 |
2014年 | 287篇 |
2013年 | 340篇 |
2012年 | 514篇 |
2011年 | 491篇 |
2010年 | 247篇 |
2009年 | 226篇 |
2008年 | 330篇 |
2007年 | 269篇 |
2006年 | 279篇 |
2005年 | 260篇 |
2004年 | 177篇 |
2003年 | 194篇 |
2002年 | 149篇 |
2001年 | 40篇 |
2000年 | 30篇 |
1999年 | 33篇 |
1998年 | 35篇 |
1997年 | 28篇 |
1996年 | 18篇 |
1995年 | 22篇 |
1994年 | 19篇 |
1993年 | 9篇 |
1992年 | 8篇 |
1991年 | 8篇 |
1990年 | 10篇 |
1989年 | 6篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 12篇 |
1985年 | 14篇 |
1984年 | 6篇 |
1983年 | 6篇 |
1979年 | 6篇 |
1977年 | 14篇 |
1976年 | 10篇 |
1975年 | 12篇 |
1974年 | 5篇 |
1972年 | 9篇 |
1970年 | 6篇 |
1926年 | 5篇 |
排序方式: 共有6028条查询结果,搜索用时 15 毫秒
991.
992.
993.
Combination of growth pattern and tumor regression identifies a high‐risk group in neoadjuvant treated rectal cancer patients 下载免费PDF全文
994.
Klaus W. Lange Joachim Hauser Katharina M. Lange Ewelina Makulska-Gertruda Yukiko Nakamura Andreas Reissmann Yuko Sakaue Tomoyuki Takano Yoshihiro Takeuchi 《Current psychiatry reports》2017,19(2):8
Attention-deficit hyperactivity disorder (ADHD) is a common behavioral disorder in children and adolescents and may persist into adulthood. Insufficient nutritional supply of long-chain polyunsaturated fatty acids (LC-PUFAs) and other components including various minerals has been suggested to play a role in the development of ADHD symptoms. This review presents the evidence regarding the role of nutritional PUFA, zinc, iron, and magnesium supplements in the treatment of ADHD with a focus on the critical evaluation of the relevant literature published from 2014 to April 2016. The evaluation of therapeutic nutritional LC-PUFA supplementation in ADHD has shown mixed and inconclusive results and at best marginal beneficial effects. The benefits of PUFAs are much smaller than the effect sizes observed for traditional pharmacological treatments of ADHD. The effectiveness of PUFA supplements in reducing medication dosage has been suggested but needs to be confirmed. Zinc, iron, and magnesium supplementation may reduce ADHD symptoms in children with or at high risk of deficiencies in these minerals. However, convincing evidence in this regard is lacking. 相似文献
995.
High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy 下载免费PDF全文
996.
Katharina Büsch Jesper Waldenström Martin Lagging Soo Aleman Ola Weiland Jan Kövamees 《Scandinavian journal of gastroenterology》2017,52(1):61-68
Purpose: The aim of this study was to estimate the prevalence of physician-diagnosed and registered chronic hepatitis C (CHC), and to estimate the reported frequencies of Charlson comorbidities compared with matched comparators from the general population.Materials and methods: Patients were identified according to ICD codes for CHC in the Swedish National Patient Register (1997–2013). Prevalence was estimated according to different patient identification algorithms and for different subgroups. Charlson comorbidities were ascertained from the same register and compared with age/sex/county of residence matched general population comparators.Results: A total of 34,633 individuals with physician-diagnosed CHC were alive in Sweden in 2013 (mean age, 49 years; 64% men), corresponding to a physician-diagnosed prevalence of 0.36%. The prevalence varied by case definition (0.22%-0.36%). The estimate dropped to 0.14% for monitored CHC disease (defined as ≥1 CHC-related visit in 2013). Overall, 41.3% of the CHC patients had ≥1 physician-registered Charlson comorbidity; the most common was liver diseases (22.1%). Compared with matched comparators from the general population (n?=?171,338), patients with CHC had more physician-diagnosed and registered diseases such as chronic pulmonary disease (10.2% vs. 4.0%), diabetes (10.6% vs. 5.5%) and liver-related cancer (1.3% vs. 0.2%; all p?<?.01). No information on behavioural factors, such as smoking, alcohol consumption or on-going illicit drug use, was available.Conclusion: The physician-diagnosed prevalence of CHC was slightly lower than previously reported estimates, and varied by case definition. The additional comorbidities observed in the CHC group should be taken into consideration, as these comorbidities add to the disease burden. 相似文献
997.
Ulrich?Friedrich?Wellner Hryhoriy?Lapshyn Detlef?K.?Bartsch Ioannis?Mintziras Ulrich?Theodor?Hopt Uwe?Wittel Hans-J?rg?Kr?mling Hubert?Preissinger-Heinzel Matthias?Anthuber Bernd?Geissler J?rg?K?ninger Katharina?Feilhauer Merten?Hommann Luisa?Peter Natascha?C.?Nüssler Thomas?Klier Ulrich?Mansmann Tobias?KeckEmail author The StuDoQ Pancreas study group members of StuDoQ|Pancreas registry of the German Society for General Visceral Surgery 《International journal of colorectal disease》2017,32(2):273-280
Purpose
The aim of this study was to assess intraoperative, postoperative, and oncologic outcome in patients undergoing laparoscopic distal pancreatectomy (LDP) versus open distal pancreatectomy (ODP) for benign and malignant lesions of the pancreas.Methods
Data from patients undergoing distal pancreatic resection were extracted from the StuDoQ|Pancreas registry of the German Society for General and Visceral Surgery. After propensity score case matching, groups of LDP and ODP were compared regarding demography, comorbidities, operative details, histopathology, and perioperative outcome.Results
At the time of data extraction, the StuDoQ|Pancreas registry included over 3000 pancreatic resections from over 50 surgical departments in Germany. Data from 353 patients undergoing ODP (n = 254) or LDP (n = 99) from September 2013 to February 2016 at 29 institutions were included in the analysis. Baseline data showed a strong selection bias in LDP patients, which disappeared after 1:1 propensity score matching. A comparison of the matched groups disclosed a significantly longer operation time, higher rate of spleen preservation, more grade A pancreatic fistula, shorter hospital stay, and increased readmissions for LDP. In the small group of patients operated for pancreatic cancer, a lower lymph node yield with a lower lymph node ratio was apparent in LDP.Conclusions
LDP needed more time but potential advantages include increased spleen preservation and shorter hospital stay, as well as a trend for less transfusion, ventilation, and mortality. LDP for pancreatic cancer was performed rarely and will need critical evaluation in the future. Data from a prospective randomized registry trial is needed to confirm these results.998.
Stéphanie?JudEmail authorView authors OrcID profile Jeroen?S.?Goede Oliver?Senn Katharina?Spanaus Markus?G.?Manz Rudolf?Benz 《Annals of hematology》2017,96(5):757-763
Interferon-α (IFNα) was the first effective drug therapy for hairy cell leukemia (HCL). Nowadays, it is used as an alternative treatment in selected patients. Due to unlimited treatment time, monitoring and early prediction of response are important. Moreover, IFNα is used in the therapy of chronic hepatitis C, where a single nucleotide polymorphism of interleukin-28B gene (IL28B) correlates with therapy response. The role of this polymorphism in therapy response of IFNα-treated patients with HCL is unknown. Thirty-seven HCL patients treated between 1978 and 2014 were included in this study. Treatment strategy and response parameters (blood cell counts, soluble interleukin-2 receptor (sIL2R), and bone marrow examination) have been assessed. Relative decrease of sIL2R was correlated with outcome parameters. Response parameters of IFNα-treated patients were correlated with IL28B polymorphism. Twenty-one patients were analyzed for the correlation of sIL2R ratio and outcome. After 1 and 3 months of therapy (IFNα or cladribine (CDA)), the median sIL2R level showed a relative decrease of 79 and 91%. These decreases significantly correlate with time to complete remission (CR, p = 0.029 and p = 0.018). Correlation analyses of IL28B genotype with outcome parameters are not significant. Six patients (16%) were diagnosed with secondary malignancies, and one death was registered (median follow-up time 14 years). IFNα is a safe, effective, and well-tolerated long-term treatment in HCL. Relative decreases of sIL2R levels correlate with time to CR and are useful as early predictor for response. There is no significant correlation between IL28B polymorphism and treatment response to IFNα. 相似文献
999.
1000.
David A. Siegel Hannah E. Reses Andrea J. Cool Craig N. Shapiro Joy Hsu Tegan K. Boehmer Cheryl R. Cornwell Elizabeth B. Gray S. Jane Henley Kimberly Lochner Amitabh B. Suthar B. Casey Lyons Linda Mattocks Kathleen Hartnett Jennifer Adjemian Katharina L. van Santen Michael Sheppard Karl A. Soetebier MAPW Pamela Logan Michael Martin Osatohamwen Idubor Pavithra Natarajan Kanta Sircar Eghosa Oyegun Joyce Dalton Cria G. Perrine Georgina Peacock Beth Schweitzer Sapna Bamrah Morris Elliot Raizes 《MMWR. Morbidity and mortality weekly report》2021,70(36):1249